Recombinant Human MAPK8

• Product Name Alternative:

  AI849689, c Jun N terminal kinase 1, C-JUN kinase 1, c-Jun N-terminal kinase 1, EC 2.7.11.24, JNK, JNK 1, JNK-46, JNK1A2, JNK21B1/2, MAP kinase 8, MAPK 8, mapk8, Mitogen activated protein kinase 8, Mitogen-activated protein kinase 8, MK08_HUMAN, p54 gamma, Prkm8

• UniProt:

  P45983

• Expression Region:

  1-427

• Host:

  E.Coli

• Tag:

  N-terminal His Tag or N-terminal His-IF2DI Tag, determined during production process

• Applications:

  Western Blot, ELISA

• Field of Research:

  Signal Transduction, Metabolism, Cardiovascular, Immunology, Neuroscience

• Purity:

  Greater than 90% as determined by SDS-PAGE.

• Form:

  Lyophilized powder

• Reconstitution:

  Centrifuge the vial before opening, reconstitute in sterile distilled water to a concentration of 0.1-1 mg/ml by gently pipetting 2-3 times, don't vortex.

• Molecular Weight:

  46.9 kDa

• Shipping Conditions:

  4°C with ice bag

• Storage Conditions:

  The lyophilized protein is stable at -20 °C for up to 1 year. For extended storage, it is recommended to further dilute in working aliquots after reconstitution. The protein solution is stable at ≤ -20 °C for 3 months, or 2-7 days at 2-8 °C under sterile conditions.Avoid repeated freeze/thaw cycle.

• Formulation:

  Lyophilized from a 0.2 μm filtered solution of 10 mM Hepes, 150 mM NaCl with 5% trehalose, pH 7.4.

• Organism Species:

  Human